Jason Campagna Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

ICPT Quotes by TradingView

Jason Campagna is Chief Medical Officer of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 20,531 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Jan 22, 2021, when has been sold 12,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.5K
0% 3M change
0% 12M change
Total Value Held $0

Jason Campagna Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 22 2021
BUY
Grant, award, or other acquisition
-
12,600 Added 38.03%
20,531 Common Stock
Jan 01 2021
SELL
Payment of exercise price or tax liability
$3,260 $24.7 p/Share
132 Reduced 1.64%
7,931 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$13,190 $24.7 p/Share
534 Reduced 6.21%
8,063 Common Stock
Oct 01 2020
SELL
Payment of exercise price or tax liability
$4,713 $42.08 p/Share
112 Reduced 1.29%
8,597 Common Stock

Also insider at

FIXX
Homology Medicines, Inc. Healthcare
Chief Medical Officer
JC

Jason Campagna

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ICPT